The Medicines Co’s experimental intravenous blood clot preventer Cangrelor, which is intended for use during angioplasty procedures, solidly outperformed commonly…
Read More
The Medicines Co’s experimental intravenous blood clot preventer Cangrelor, which is intended for use during angioplasty procedures, solidly outperformed commonly…
Read MoreNearly 28 percent of adults ages 20 to 59 hold multiple drug prescriptions at any given time, per CDC data.…
Read MoreAged whiskey, high-speed laptops, extra-ply toilet paper–sometimes, ponying up for name brands buys higher quality. But when it comes to…
Read More